209 related articles for article (PubMed ID: 28099939)
1. Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome.
Cesarini V; Martini M; Vitiani LR; Gravina GL; Di Agostino S; Graziani G; D'Alessandris QG; Pallini R; Larocca LM; Rossi P; Jannini EA; Dolci S
Oncotarget; 2017 Feb; 8(8):13223-13239. PubMed ID: 28099939
[TBL] [Abstract][Full Text] [Related]
2. Phosphodiesterase 5/protein kinase G signal governs stemness of prostate cancer stem cells through Hippo pathway.
Liu N; Mei L; Fan X; Tang C; Ji X; Hu X; Shi W; Qian Y; Hussain M; Wu J; Wang C; Lin S; Wu X
Cancer Lett; 2016 Aug; 378(1):38-50. PubMed ID: 27179930
[TBL] [Abstract][Full Text] [Related]
3. Impact of PARP-1 and DNA-PK expression on survival in patients with glioblastoma multiforme.
Kase M; Vardja M; Lipping A; Asser T; Jaal J
Radiother Oncol; 2011 Oct; 101(1):127-31. PubMed ID: 21775006
[TBL] [Abstract][Full Text] [Related]
4. RAD18 mediates resistance to ionizing radiation in human glioma cells.
Xie C; Wang H; Cheng H; Li J; Wang Z; Yue W
Biochem Biophys Res Commun; 2014 Feb; 445(1):263-8. PubMed ID: 24518219
[TBL] [Abstract][Full Text] [Related]
5. Poly(ADP-ribosyl)ation is required for p53-dependent signal transduction induced by radiation.
Wang X; Ohnishi K; Takahashi A; Ohnishi T
Oncogene; 1998 Dec; 17(22):2819-25. PubMed ID: 9879988
[TBL] [Abstract][Full Text] [Related]
6. miR-708 acts as a tumor suppressor in human glioblastoma cells.
Guo P; Lan J; Ge J; Nie Q; Mao Q; Qiu Y
Oncol Rep; 2013 Aug; 30(2):870-6. PubMed ID: 23754151
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.
Kegelman TP; Wu B; Das SK; Talukdar S; Beckta JM; Hu B; Emdad L; Valerie K; Sarkar D; Furnari FB; Cavenee WK; Wei J; Purves A; De SK; Pellecchia M; Fisher PB
Proc Natl Acad Sci U S A; 2017 Jan; 114(2):370-375. PubMed ID: 28011764
[TBL] [Abstract][Full Text] [Related]
8. PAX6 suppresses the invasiveness of glioblastoma cells and the expression of the matrix metalloproteinase-2 gene.
Mayes DA; Hu Y; Teng Y; Siegel E; Wu X; Panda K; Tan F; Yung WK; Zhou YH
Cancer Res; 2006 Oct; 66(20):9809-17. PubMed ID: 17047041
[TBL] [Abstract][Full Text] [Related]
9. Activation of cGMP/PKG/p65 signaling associated with PDE5-Is downregulates CCL5 secretion by CD8
Jin S; Xiang P; Liu J; Yang Y; Hu S; Sheng J; He Q; Yu W; Han W; Jin J; Peng J
Prostate; 2019 Jun; 79(8):909-919. PubMed ID: 30958912
[TBL] [Abstract][Full Text] [Related]
10. O6-Methylguanine-DNA methyltransferase is a novel negative effector of invasion in glioblastoma multiforme.
Chahal M; Abdulkarim B; Xu Y; Guiot MC; Easaw JC; Stifani N; Sabri S
Mol Cancer Ther; 2012 Nov; 11(11):2440-50. PubMed ID: 22986464
[TBL] [Abstract][Full Text] [Related]
11. Expression and Function of Phosphodiesterase Type 5 in Human Breast Cancer Cell Lines and Tissues: Implications for Targeted Therapy.
Catalano S; Campana A; Giordano C; Győrffy B; Tarallo R; Rinaldi A; Bruno G; Ferraro A; Romeo F; Lanzino M; Naro F; Bonofiglio D; Andò S; Barone I
Clin Cancer Res; 2016 May; 22(9):2271-82. PubMed ID: 26667489
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
[TBL] [Abstract][Full Text] [Related]
13. Essential role of the cGMP/PKG signaling pathway in regulating the proliferation and survival of human renal carcinoma cells.
Ren Y; Zheng J; Yao X; Weng G; Wu L
Int J Mol Med; 2014 Nov; 34(5):1430-8. PubMed ID: 25244411
[TBL] [Abstract][Full Text] [Related]
14. Suppression of cyclic GMP-specific phosphodiesterase 5 promotes apoptosis and inhibits growth in HT29 cells.
Zhu B; Vemavarapu L; Thompson WJ; Strada SJ
J Cell Biochem; 2005 Feb; 94(2):336-50. PubMed ID: 15526282
[TBL] [Abstract][Full Text] [Related]
15. Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme.
Yan W; Zhang W; Sun L; Liu Y; You G; Wang Y; Kang C; You Y; Jiang T
Brain Res; 2011 Sep; 1411():108-15. PubMed ID: 21831363
[TBL] [Abstract][Full Text] [Related]
16. How do phosphodiesterase-5 inhibitors affect cancer? A focus on glioblastoma multiforme.
Sanati M; Aminyavari S; Mollazadeh H; Bibak B; Mohtashami E; Afshari AR
Pharmacol Rep; 2022 Apr; 74(2):323-339. PubMed ID: 35050491
[TBL] [Abstract][Full Text] [Related]
17. PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant glioma.
Majuelos-Melguizo J; Rodríguez MI; López-Jiménez L; Rodríguez-Vargas JM; Martí Martín-Consuegra JM; Serrano-Sáenz S; Gavard J; de Almodóvar JM; Oliver FJ
Oncotarget; 2015 Mar; 6(7):4790-803. PubMed ID: 25576921
[TBL] [Abstract][Full Text] [Related]
18. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A
Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189
[TBL] [Abstract][Full Text] [Related]
19. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.
Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS
Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534
[TBL] [Abstract][Full Text] [Related]
20. FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells.
Maachani UB; Shankavaram U; Kramp T; Tofilon PJ; Camphausen K; Tandle AT
Oncotarget; 2016 Nov; 7(47):77365-77377. PubMed ID: 27764801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]